Event production company Zibrant have won contracts which are expected to double its turnover in the pharmaceutical sector and assert the company as a leading organisation for healthcare meetings and events management.
The new appointments include a long-term global preferred supplier agreement as well as a significant one-year contract along with a series of headline events for a major pharmaceutical brand.
Commencing with immediate effect, the contracts will draw on the company’s substantial strategic meetings management experience as well as its award winning creative department.
The wins will also open up new career opportunities at Zibrant with the creation of three new healthcare specialist roles in the company’s operations department.
Hannah Wilkinson, director of sales and business strategy at Zibrant, commented: “We have built a strong reputation in a market that requires very specific expertise and exacting attention to detail. These new contracts acknowledge our capabilities and understanding of the requisite compliance that pharmaceutical and healthcare procurement teams need.”
Zibrant was recently acquired by BCD Meetings & Events (BCD M&E), a global leader in the meetings and events industry. The acquisition will strengthen and diversify its events business in the European market.
